Takeshi Tsujino Selected Research

Systolic Heart Failure

9/2007	Characterization of left ventricular filling abnormalities and its relation to elevated plasma brain natriuretic peptide level in acute to chronic diastolic heart failure.
1/2006	Left ventricular diastolic dysfunction in diabetic patients: pathophysiology and therapeutic implications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takeshi Tsujino Research Topics

Disease

16	Neoplasms (Cancer) 07/2018 - 03/2002
13	Pathologic Constriction (Stenosis) 10/2019 - 10/2006
13	Heart Failure 01/2018 - 01/2006
13	Hypertension (High Blood Pressure) 12/2016 - 05/2002
11	Pancreatic Neoplasms (Pancreatic Cancer) 09/2011 - 05/2006
10	Anemia 12/2020 - 09/2008
9	Pancreatitis 01/2014 - 03/2002
8	Diabetes Mellitus 01/2019 - 01/2006
8	Cholecystitis 01/2016 - 03/2002
6	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 01/2008
6	Fibrosis (Cirrhosis) 01/2022 - 04/2007
6	Aortic Valve Stenosis (Aortic Stenosis) 09/2013 - 10/2010
6	Hypertrophy 06/2013 - 01/2008
6	Cholangitis 03/2013 - 11/2005
5	Biliary Tract Neoplasms (Biliary Tract Cancer) 04/2012 - 01/2009
5	Autoimmune Pancreatitis 11/2010 - 11/2003
5	Hypertriglyceridemia 04/2005 - 11/2002
4	Left Ventricular Dysfunction 11/2016 - 04/2007
4	Hypoxia (Hypoxemia) 01/2016 - 03/2009
4	Gastric Outlet Obstruction 08/2014 - 04/2012
4	Chronic Renal Insufficiency 06/2013 - 01/2011
4	Hyperinsulinism (Hyperinsulinemia) 05/2009 - 01/2003
3	Proteinuria 01/2022 - 03/2011
3	Lymphatic Metastasis 12/2019 - 05/2008
3	Vascular Remodeling 01/2016 - 06/2013
3	Cardiomegaly (Heart Hypertrophy) 06/2015 - 01/2008
3	Diastolic Heart Failure 07/2014 - 09/2007
3	Neoplasm Metastasis (Metastasis) 05/2012 - 08/2010
3	Gallbladder Neoplasms (Gallbladder Cancer) 05/2010 - 05/2006
3	Atherosclerosis 01/2010 - 04/2003
2	Inflammation (Inflammations) 01/2022 - 02/2010
2	Edema (Dropsy) 01/2019 - 01/2007
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2018 - 07/2006
2	Iron Deficiencies 06/2015 - 09/2013
2	Type 2 Diabetes Mellitus (MODY) 09/2013 - 01/2010
2	Sclerosing Cholangitis 07/2010 - 05/2006
2	Hyperlipidemias (Hyperlipidemia) 07/2010 - 04/2003
2	Cholangiocarcinoma 05/2010 - 01/2008
2	Acute Cholecystitis 04/2009 - 04/2009
2	Bile Duct Neoplasms (Bile Duct Cancer) 05/2008 - 05/2006
2	Chronic Pancreatitis 12/2007 - 05/2006
2	Thiamine Deficiency 11/2007 - 01/2007
2	Beriberi 11/2007 - 01/2007
2	Systolic Heart Failure 09/2007 - 01/2006

Drug/Important Bio-Agent (IBA)

16	IronIBA 03/2022 - 03/2009
11	Gemcitabine FDA Link 04/2012 - 01/2008
9	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019 - 05/2007
8	SaltsIBA 12/2020 - 05/2002
6	PlasticsIBA 10/2019 - 05/2008
6	Triglycerides (Triacylglycerol)IBA 07/2018 - 11/2002
6	DiureticsIBA 07/2017 - 01/2006
5	MetalsIBA 10/2019 - 03/2002
5	Erythropoietin FDA Link 11/2017 - 03/2009
5	Pharmaceutical PreparationsIBA 01/2012 - 04/2003
5	Interleukin-18 (Interleukin 18)IBA 10/2010 - 05/2003
4	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 07/2017 - 01/2007
4	Dietary IronIBA 12/2016 - 06/2013
4	urinastatin (MR 20)IBA 12/2013 - 04/2005
4	BezafibrateIBA 07/2010 - 01/2003
3	HDL CholesterolIBA 07/2018 - 05/2011
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2014 - 01/2010
3	CytokinesIBA 03/2010 - 11/2005
3	CalciumIBA 07/2006 - 01/2003
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2022 - 03/2022
2	CholesterolIBA 07/2018 - 05/2013
2	Furosemide (Lasix)FDA LinkGeneric 07/2017 - 01/2012
2	azosemideIBA 07/2017 - 01/2012
2	Indicators and Reagents (Reagents)IBA 05/2017 - 01/2008
2	Amlodipine (Norvasc)FDA LinkGeneric 11/2016 - 03/2014
2	CollagenIBA 02/2016 - 04/2007
2	AldosteroneIBA 03/2014 - 09/2008
2	Amylases FDA Link 01/2014 - 10/2011
2	SteroidsIBA 01/2014 - 11/2003
2	Risperidone (Risperdal Consta)FDA LinkGeneric 12/2013 - 08/2013
2	Type 1 Angiotensin ReceptorIBA 09/2013 - 04/2007
2	Therapeutic UsesIBA 06/2013 - 01/2012
2	perfluoro- 2,2,2',2'- tetramethyl- 4,4'- bis(1,3- dioxolane)IBA 03/2013 - 05/2012
2	EnzymesIBA 05/2011 - 09/2002
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2011 - 01/2006
2	S 1 (combination)IBA 04/2011 - 05/2010
2	HepcidinsIBA 04/2011 - 02/2010
2	Contrast MediaIBA 01/2011 - 01/2010
2	C-Reactive ProteinIBA 08/2010 - 03/2010
2	Interleukin-6 (Interleukin 6)IBA 03/2010 - 02/2010
2	rho-Associated KinasesIBA 01/2010 - 01/2008
2	Biomarkers (Surrogate Marker)IBA 09/2008 - 11/2005
2	Thiamine (Aneurin)FDA Link 11/2007 - 01/2007
2	Protease Inhibitors (Protease Inhibitor)IBA 07/2007 - 04/2005

Therapy/Procedure

24	Stents 10/2019 - 03/2002
11	Therapeutics 01/2021 - 11/2003
8	Drug Therapy (Chemotherapy) 12/2019 - 01/2009
6	Liver Transplantation 10/2019 - 07/2007
6	Self Expandable Metallic Stents 08/2014 - 05/2008
4	Catheters 03/2013 - 10/2006
3	Cholecystectomy 01/2016 - 04/2009
3	Combination Drug Therapy (Combination Chemotherapy) 12/2011 - 01/2009
2	Surgical Instruments (Clip) 12/2016 - 03/2011
2	Endoscopic Sphincterotomy 01/2016 - 01/2011
2	Radiotherapy 05/2012 - 01/2007
2	Gastrectomy 01/2010 - 01/2007